Pfizer (PFE) Tax Rate (2009 - 2026)

Pfizer has disclosed Tax Rate across 18 years of filings, most recently posting 14.54% for Q1 2026.

• In Q1 2026, Tax Rate rose 2133.0% year-over-year to 14.54%; the TTM figure through Mar 2026 stood at 4.86% (up 297.0% YoY), while the FY2025 annual figure was 3.54%, down 319.0% from the prior year.
• Tax Rate improved to 14.54% in Q1 2026, from 0.12% in the prior quarter.
• Over the last five years, Tax Rate for PFE reached as high as 130.1% in Q2 2024 and fell as low as 6.79% in Q1 2025.
• The 5-year median for Tax Rate is 8.56% (2024), against an average of 15.75%.
• Annual changes were most pronounced in 2024 — Tax Rate jumped 13323 bps — and 2025, when it sank 12547 bps.
• A 5-year view of Tax Rate shows it stood at 3.96% in 2022, then soared by 378 bps to 18.89% in 2023, then plunged by 74 bps to 4.96% in 2024, then tumbled by 98 bps to 0.12% in 2025, then jumped by 11839 bps to 14.54% in 2026.
• According to Business Quant data, Tax Rate over the past three periods registered 14.54%, 0.12%, and 6.48% for Q1 2026, Q4 2025, and Q3 2025 respectively.